Coblopasvir dihydrochloride | HCV NS5A inhibitor

Chemical Structure : Coblopasvir dihydrochloride

Catalog No.: PC-22913Not For Human Use, Lab Use Only.

Coblopasvir (KW136, KW-136) dihydrochloride is a novel HCV NS5A inhibitor under development for treatment of HCV infection.

Packing	Price	Stock	Quantity
25 mg		Get quote
50 mg		Get quote
100 mg		Get quote

Get Quotation Now

or Bulk Inquiry

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Biological Activity

Coblopasvir (KW136, KW-136) dihydrochloride is a novel HCV NS5A inhibitor under development for treatment of HCV infection.

M.Wt	855.82
Formula	C41H52Cl2N8O8
Appearance	Solid
CAS No.
Storage	Solide Powder -20°C 12 Months; 4°C 6 Months	In Solvent -80°C 6 Months; -20°C 6 Months
Shipping
Solubility	10 mM in DMSO
Chemical Name/SMILES	Methyl ((S)-1-((S)-2-(5-(7-(4-(2-((S)-1-((methoxycarbonyl)-L-valyl)pyrrolidin-2-yl)-1H-imidazol-5-yl)phenyl)benzo[d][1,3]dioxol-4-yl)-1H-imidazol-2-yl)pyrrolidin-1-yl)-3-methyl-1-oxobutan-2-yl)carbamate dihydrochloride

1. Gao Y, et al. Liver Int. 2020;40(11):2685-2693.